+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Women's Health Diagnostics Market by Disease Indication (Cardiovascular Conditions, Infectious Diseases, Metabolic Disorders), Test Type (Instruments, Kits And Reagents, Software And Services), Technology, End User, Sample Type, Distribution Channel - Global Forecast 2025-2030- Product Image
Women's Health Diagnostics Market by Disease Indication (Cardiovascular Conditions, Infectious Diseases, Metabolic Disorders), Test Type (Instruments, Kits And Reagents, Software And Services), Technology, End User, Sample Type, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Women's Health Diagnostics Market by Disease Indication (Cardiovascular Conditions, Infectious Diseases, Metabolic Disorders), Test Type (Instruments, Kits And Reagents, Software And Services), Technology, End User, Sample Type, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829897
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The women’s health diagnostics market is undergoing rapid transformation, presenting new opportunities and challenges for industry leaders seeking to leverage innovation, optimize operational efficiency, and strengthen market position. This report distills actionable insights for senior decision-makers navigating this evolving landscape.

Market Snapshot: Women’s Health Diagnostics Market Growth and Trends

The Women’s Health Diagnostics Market grew from USD 46.82 billion in 2024 to USD 51.43 billion in 2025, with an anticipated CAGR of 9.49%, reaching USD 80.67 billion by 2030. Segmental growth is driven by adoption of advanced diagnostic solutions, increasing emphasis on early detection, and growing integration of AI in clinical workflows. Progress in point-of-care testing and tailored screening protocols are also accelerating adoption across global healthcare systems, positioning this market for continued expansion and stakeholder engagement.

Scope & Segmentation of the Women’s Health Diagnostics Market

This report offers detailed segmentation to help companies target growth, assess opportunities, and formulate strategic initiatives:

  • Disease Indications: Cardiovascular conditions, infectious diseases (including HIV and human papillomavirus), metabolic disorders (diabetes, thyroid disorders), oncology (breast, cervical, ovarian cancers), pregnancy and fertility (ovulation, pregnancy tests).
  • Test Types: Instruments (benchtop, point-of-care), kits and reagents (immunoassays, lateral flow, molecular diagnostics), software and supporting services (informational software, analytics services).
  • Technological Platforms: Biochemical analysis (colorimetry, fluorometry), immunoassay methods, molecular diagnostics (next-generation sequencing, PCR technologies).
  • End Users: Home care settings, hospital and diagnostic centers, research laboratories.
  • Sample Types: Blood, saliva, tissue, urine.
  • Distribution Channels: Direct sales, distributors, online channels.
  • Geographic Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).

Key Takeaways for Industry Leaders

  • Emerging technologies, particularly molecular sequencing and AI-enabled analytics, are reshaping diagnostic precision and supporting the transition to more personalized women’s healthcare delivery.
  • Strategic alliances between diagnostics manufacturers, biotech startups, and academic institutions expedite innovation, facilitate integrated solutions, and address previously unmet diagnostic needs.
  • Decentralized and point-of-care diagnostics are gaining prominence, particularly in home care and rural settings, accelerating patient outcomes and supporting continuous disease monitoring.
  • Integrated digital solutions improve patient engagement by securely delivering test results through mobile applications and fostering adherence to screening protocols.
  • Companies are refining supply chain and product strategies in response to shifting regulatory frameworks and the broader adoption of subscription-based diagnostics software.
  • Cross-functional collaboration between R&D, regulatory, and commercial teams enhances time-to-market for novel diagnostic offerings, giving organizations a clear competitive edge.

United States Tariff Impact on the Women’s Health Diagnostics Market

Recent tariff measures in the United States have influenced costs throughout diagnostics supply chains by raising procurement expenses for imported instruments and reagents. Organizations are responding with strategies such as diversifying regional suppliers, enhancing domestic sourcing, renegotiating contracts, and optimizing inventory management. These approaches aim to safeguard margin structures and supply continuity in key diagnostic testing segments, particularly oncology and infectious disease panels.

Methodology & Data Sources for Robust Market Insights

The insights in this women’s health diagnostics market report derive from a rigorous multi-method methodology. Primary data was collected through interviews with industry leaders, clinical specialists, and key opinion leaders. Secondary research involved analysis of peer-reviewed literature, regulatory documentation, and industry reports. Data was validated through cross-source triangulation and expert panels to ensure reliability and actionable intelligence for decision-makers.

Why This Report Matters for Strategic Decision-Makers

  • Enables formulation of tailored business strategies by providing comprehensive segmentation and regional perspectives on the women’s health diagnostics market.
  • Delivers clear, actionable recommendations addressing regulatory hurdles, technological disruption, and evolving patient needs.
  • Supports risk-mitigation and investment planning through data-driven insight into supply chain, tariff, and competitive dynamics.

Conclusion & Forward View

This market report equips senior leaders with the intelligence to capitalize on innovation and navigate operational complexity in women’s health diagnostics. By aligning strategies with evolving trends, organizations can drive sustainable market growth and deliver enhanced patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing demand for AI-enabled fertility tracking wearables providing personalized ovulation and cycle predictions
5.2. Rapid expansion of telehealth-based point-of-care tests for early preeclampsia screening in underserved communities
5.3. Integration of non-invasive prenatal liquid biopsy assays for comprehensive fetal genetic anomaly detection
5.4. Adoption of personalized multi-hormone profiling diagnostics to tailor individualized menopause management plans
5.5. Development of rapid multiplex molecular platforms for simultaneous detection of multiple sexually transmitted pathogens
5.6. Emergence of at-home endometrial receptivity tests improving implantation success rates in in vitro fertilization cycles
5.7. Implementation of telemonitoring solutions combined with at-home sampling kits for cardiovascular risk assessment in women
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Women’s Health Diagnostics Market, by Disease Indication
8.1. Introduction
8.2. Cardiovascular Conditions
8.3. Infectious Diseases
8.3.1. HIV
8.3.2. Human Papillomavirus
8.4. Metabolic Disorders
8.4.1. Diabetes
8.4.2. Thyroid Disorders
8.5. Oncology
8.5.1. Breast Cancer
8.5.2. Cervical Cancer
8.5.3. Ovarian Cancer
8.6. Pregnancy And Fertility
8.6.1. Ovulation Test
8.6.2. Pregnancy Test
9. Women’s Health Diagnostics Market, by Test Type
9.1. Introduction
9.2. Instruments
9.2.1. Benchtop Instruments
9.2.2. Point Of Care Instruments
9.3. Kits And Reagents
9.3.1. Immunoassays
9.3.2. Lateral Flow Assays
9.3.3. Molecular Diagnostics Kits
9.4. Software And Services
9.4.1. Informational Software
9.4.2. Services
10. Women’s Health Diagnostics Market, by Technology
10.1. Introduction
10.2. Biochemical Analysis
10.2.1. Colorimetry
10.2.2. Fluorometry
10.3. Immunoassay
10.4. Molecular Diagnostics
10.4.1. Next Generation Sequencing
10.4.2. PCR
11. Women’s Health Diagnostics Market, by End User
11.1. Introduction
11.2. Home Care Settings
11.3. Hospital And Diagnostic Centers
11.4. Research Laboratories
12. Women’s Health Diagnostics Market, by Sample Type
12.1. Introduction
12.2. Blood
12.3. Saliva
12.4. Tissue
12.5. Urine
13. Women’s Health Diagnostics Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Distributors
13.4. Online Channels
14. Americas Women’s Health Diagnostics Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Women’s Health Diagnostics Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Women’s Health Diagnostics Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. AccuBioTech Co., Ltd.
17.3.3. Becton, Dickinson and Company
17.3.4. Biomérieux SA
17.3.5. Cardinal Health, Inc.
17.3.6. Carestream Health, Inc.
17.3.7. Chembio Diagnostic Systems, Inc.
17.3.8. Cook Medical, Inc.
17.3.9. Danaher Corporation
17.3.10. DIALAB GmbH
17.3.11. EKF Diagnostics Holdings PLC
17.3.12. F. Hoffmann-La Roche Ltd.
17.3.13. FUJIFILM Holdings Corporation
17.3.14. GE Healthcare
17.3.15. Guided Therapeutics, Inc.
17.3.16. Hologic, Inc.
17.3.17. Koninklijke Philips N.V.
17.3.18. MedGyn Products, Inc.
17.3.19. NeuroLogica Corporation
17.3.20. Nova Biomedical
17.3.21. Perkinelmer Inc.
17.3.22. Quest Diagnostics Incorporated
17.3.23. Siemens AG
17.3.24. SuperSonic Imagine
17.3.25. Werfen, S.A.
17.3.26. OSI Systems, Inc.
17.3.27. Hill-Rom Holdings, Inc.
17.3.28. Bio-Rad Laboratories, Inc.
17.3.29. Sekisui Diagnostics, LLC
17.3.30. Thermo Fisher Scientific Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. WOMEN’S HEALTH DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. WOMEN’S HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. WOMEN’S HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. WOMEN’S HEALTH DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 28. WOMEN’S HEALTH DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 29. WOMEN’S HEALTH DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 30. WOMEN’S HEALTH DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. WOMEN’S HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR CONDITIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR CONDITIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY THYROID DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY THYROID DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVULATION TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVULATION TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFORMATIONAL SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFORMATIONAL SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COLORIMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COLORIMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FLUOROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FLUOROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITAL AND DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITAL AND DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 185. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 186. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 187. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 188. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 189. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 190. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 191. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 192. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 193. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2018-2024 (USD MILLION)
TABLE 194. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2025-2030 (USD MILLION)
TABLE 195. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 196. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 197. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 198. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 199. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 200. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 201. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 202. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 203. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2018-2024 (USD MILLION)
TABLE 206. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2025-2030 (USD MILLION)
TABLE 207. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 208. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 209. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 212. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 213. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 216. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 217. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 218. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 219. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 220. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 221. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 222. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 223. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2018-2024 (USD MILLION)
TABLE 224. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2025-2030 (USD MILLION)
TABLE 225. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 226. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 227. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 228. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 229. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 230. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 231. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 232. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 233. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 239. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 242. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 243. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL ANALYSIS, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORD

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Becton, Dickinson and Company
  • Biomérieux SA
  • Cardinal Health, Inc.
  • Carestream Health, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cook Medical, Inc.
  • Danaher Corporation
  • DIALAB GmbH
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Guided Therapeutics, Inc.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • MedGyn Products, Inc.
  • NeuroLogica Corporation
  • Nova Biomedical
  • Perkinelmer Inc.
  • Quest Diagnostics Incorporated
  • Siemens AG
  • SuperSonic Imagine
  • Werfen, S.A.
  • OSI Systems, Inc.
  • Hill-Rom Holdings, Inc.
  • Bio-Rad Laboratories, Inc.
  • Sekisui Diagnostics, LLC
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 51.43 Billion
Forecasted Market Value ( USD ) by 2030 $ 80.67 Billion
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Women's Health Diagnostics Market Size, Share, & Trends Analysis Report By Application, By End Use, By Region, 2025 - 2030 - Product Image

Women's Health Diagnostics Market Size, Share, & Trends Analysis Report By Application, By End Use, By Region, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2025-2033 - Product Image

Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2025-2033

  • Report
  • 146 Pages
  • Global
From
Womens Health Diagnostics Market Report 2025 - Product Image

Womens Health Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Women Health Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Women Health Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Women's Health Applications Market by Application (Fertility Management, General Wellness, Menstrual Health), Product Type (Diagnostic Tests, Mobile Applications, Software Platforms), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Women's Health Applications Market by Application (Fertility Management, General Wellness, Menstrual Health), Product Type (Diagnostic Tests, Mobile Applications, Software Platforms), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From

About the Women Health Diagnostic Market

The Women Health Diagnostic market is a sector of the healthcare industry that focuses on the diagnosis and treatment of women's health issues. It includes a range of services, from preventive care to specialized treatments for conditions such as infertility, endometriosis, and menopause. Diagnostic tests are used to identify and monitor conditions, and treatments may include medications, lifestyle changes, and surgery. The market also includes products and services related to women's health, such as fertility tracking apps and hormone replacement therapy. The Women Health Diagnostic market is growing as more women seek out specialized care for their health needs. This growth is driven by increased awareness of women's health issues, improved access to healthcare, and advances in technology. Companies in the Women Health Diagnostic market include Athenahealth, Inc., Cerner Corporation, Epic Systems Corporation, and Allscripts Healthcare Solutions, Inc. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.